Differentiating Euthyroid sick syndrome from other diseases: Difference between revisions
Aditya Ganti (talk | contribs) Undo revision 1342628 by Aditya Ganti (talk) |
Ahmed Younes (talk | contribs) No edit summary |
||
(4 intermediate revisions by 3 users not shown) | |||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
[[Image:Home_logo1.png|right|250px|link=https://www.wikidoc.org/index.php/Euthyroid_sick_syndrome]] | |||
{{CMG}}{{AE}} {{Akshun}} | {{CMG}}{{AE}} {{Akshun}} | ||
Line 26: | Line 26: | ||
|- | |- | ||
| colspan="2" rowspan="3" style="background:#DCDCDC;" |Euthyroid sick syndrome | | colspan="2" rowspan="3" style="background:#DCDCDC;" |Euthyroid sick syndrome | ||
|Mild | |align="center" style="background:#DCDCDC;" |Mild | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | + | | align="center" style="padding: 5px 5px; background: #F5F5F5;" | + | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | - | | align="center" style="padding: 5px 5px; background: #F5F5F5;" | - | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | - | | align="center" style="padding: 5px 5px; background: #F5F5F5;" | - | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | | | align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | | | align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |'''''↓''''' | | align="center" style="padding: 5px 5px; background: #F5F5F5;" |'''''↓''''' | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | '''↑''' | | align="center" style="padding: 5px 5px; background: #F5F5F5;" | '''↑''' | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | - | | align="center" style="padding: 5px 5px; background: #F5F5F5;" | - | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | | | align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | - | | align="center" style="padding: 5px 5px; background: #F5F5F5;" | - | ||
| rowspan="3" align="left" style="padding: 5px 5px; background: #F5F5F5;" | | | rowspan="3" align="left" style="padding: 5px 5px; background: #F5F5F5;" | | ||
*Additional findings of underlying condition | * Additional findings of underlying condition | ||
|- | |- | ||
|Moderate | |align="center" style="background:#DCDCDC;" |Moderate | ||
| + | | + | ||
| - | | - | ||
| - | | - | ||
| | |Normal | ||
| | /↓ | ||
|Normal | |||
/↓ | |||
|'''''↓''''' | |'''''↓''''' | ||
|'''↑''' | |'''↑''' | ||
| - | | - | ||
| | |Normal/↓ | ||
| - | | - | ||
|- | |- | ||
|Severe | |align="center" style="background:#DCDCDC;" |Severe | ||
| + | | + | ||
| - | | - | ||
Line 72: | Line 74: | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |'''↑''' | | align="center" style="padding: 5px 5px; background: #F5F5F5;" |'''↑''' | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |'''''↓''''' | | align="center" style="padding: 5px 5px; background: #F5F5F5;" |'''''↓''''' | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | | | align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal/'''''↓''''' | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal | | align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | | | align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal/'''↑''' | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal | | align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |'''↑''' | | align="center" style="padding: 5px 5px; background: #F5F5F5;" |'''↑''' | ||
Line 88: | Line 90: | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal | | align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal | | align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | | | align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal/'''↑''' | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal | | align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal | | align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal | ||
Line 102: | Line 104: | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal | | align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal | | align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | | | align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal/'''↑''' | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal | | align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal | | align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal | ||
Line 133: | Line 135: | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |'''↑''' | | align="center" style="padding: 5px 5px; background: #F5F5F5;" |'''↑''' | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal | | align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | | | align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal/'''↑''' | ||
| align="left" style="padding: 5px 5px; background: #F5F5F5;" | | | align="left" style="padding: 5px 5px; background: #F5F5F5;" | | ||
* Asymptomatic | * Asymptomatic | ||
Line 142: | Line 144: | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | - | | align="center" style="padding: 5px 5px; background: #F5F5F5;" | - | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | - | | align="center" style="padding: 5px 5px; background: #F5F5F5;" | - | ||
| rowspan="2" align="center" style="padding: 5px 5px; background: #F5F5F5;" | | | rowspan="2" align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal/'''''↓''''' | ||
| rowspan="2" align="center" style="padding: 5px 5px; background: #F5F5F5;" | | | rowspan="2" align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal/'''''↓''''' | ||
| rowspan="2" align="center" style="padding: 5px 5px; background: #F5F5F5;" | | | rowspan="2" align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal/'''''↓''''' | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |'''↓''' | | align="center" style="padding: 5px 5px; background: #F5F5F5;" |'''↓''' | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal | | align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal | ||
Line 168: | Line 170: | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | - | | align="center" style="padding: 5px 5px; background: #F5F5F5;" | - | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |'''↑''' | | align="center" style="padding: 5px 5px; background: #F5F5F5;" |'''↑''' | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | | | align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal/'''''↓''''' | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | | | align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal/'''''↓''''' | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal | | align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal | | align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal |
Latest revision as of 19:22, 25 February 2019
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Akshun Kalia M.B.B.S.[2]
Overview
Euthyroid sick syndrome must be differentiated from other causes of hypothyroidism on the basis of clinical features and laboratory findings. In euthyroid sick syndrome, serum T3 is decreased more than T4, the T3RU (T3 resin uptake) is high, and TSH is normal or mildly decreased. In primary hypothyroidism, serum T4 is decreased more than T3, the T3RU (T3 resin uptake) is low, and TSH is increased. Other causes of hypothyroidism include transient hypothyroidism, sub-clinical hypothyroidism, central hypothyroidism (pituitary or hypothalamic) and peripheral resistance to TSH/TRH.
Differentiating Euthyroid sick syndrome from other Diseases
Euthyroid sick syndrome must be differentiated from other causes of hypothyroidism on the basis of history and symptoms and laboratory findings:[1][2][3]
Disease | History and symptoms | Laboratory findings | Additional findings | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Fever | Goiter | Pain | TSH | Free T4 | T3 | T3RU | Thyroglobin | TRH | TPOAb | ||||
Euthyroid sick syndrome | Mild | + | - | - | Normal | Normal | ↓ | ↑ | - | Normal | - |
| |
Moderate | + | - | - | Normal
/↓ |
Normal
/↓ |
↓ | ↑ | - | Normal/↓ | - | |||
Severe | + | - | - | ↓ | N/↓ | ↓ | ↑ | - | ↓ | - | |||
Primary hypothyroidism | Autoimmune | + | +/-
Diffuse |
- | ↑ | ↓ | Normal/↓ | Normal | Normal/↑ | Normal | ↑ |
| |
Thyroiditis | + | +/- | + | ↑ | ↓ | Normal | Normal | Normal/↑ | Normal | Normal |
| ||
Others | - | +/- | - | ↑ | ↓ | Normal | Normal | Normal/↑ | Normal | Normal |
| ||
Transient hypothyroidism | +/- | - | +/- | ↑ | ↑ | Normal | Normal | ↑ | Normal | Normal |
| ||
Subclinical hypothyroidism | - | - | - | ↑ | Normal | Normal | Normal | ↑ | Normal | Normal/↑ |
| ||
Central Hypothyroidism | Pituitary | + | - | - | Normal/↓ | Normal/↓ | Normal/↓ | ↓ | Normal | Normal | Normal |
| |
Hypothalamus | + | - | - | ↑ | Normal | ↓ | Normal |
| |||||
Resistance to TSH/TRH | - | - | - | ↑ | Normal/↓ | Normal/↓ | Normal | Normal | ↑/↓ | Normal |
|
References
- ↑ McDermott MT (2009). "In the clinic. Hypothyroidism". Ann. Intern. Med. 151 (11): ITC61. doi:10.7326/0003-4819-151-11-200912010-01006. PMID 19949140.
- ↑ Hollowell JG, Staehling NW, Flanders WD, Hannon WH, Gunter EW, Spencer CA, Braverman LE (2002). "Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III)". J. Clin. Endocrinol. Metab. 87 (2): 489–99. doi:10.1210/jcem.87.2.8182. PMID 11836274.
- ↑ Aoki Y, Belin RM, Clickner R, Jeffries R, Phillips L, Mahaffey KR (2007). "Serum TSH and total T4 in the United States population and their association with participant characteristics: National Health and Nutrition Examination Survey (NHANES 1999-2002)". Thyroid. 17 (12): 1211–23. doi:10.1089/thy.2006.0235. PMID 18177256.